Prostaglandin E2 stimulates expression of osmoprotective genes in MDCK cells and promotes survival under hypertonic conditions.

Publisher: Cambridge Univ. Press Country of Publication: England NLM ID: 0266262 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0022-3751 (Print) Linking ISSN: 00223751 NLM ISO Abbreviation: J Physiol Subsets: MEDLINE

Publication: Oxford : Blackwell : Cambridge Univ. Press
Original Publication: London, Cambridge Univ. Press.

Aldehyde Reductase/*metabolism ; Carrier Proteins/*metabolism ; Dinoprostone/*physiology ; HSP70 Heat-Shock Proteins/*metabolism ; Kidney Medulla/*metabolism; Aldehyde Reductase/genetics ; Animals ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Carrier Proteins/genetics ; Caspase 3/genetics ; Caspase 3/metabolism ; Cell Line ; Cell Survival ; Dogs ; GABA Plasma Membrane Transport Proteins ; Gene Expression Regulation ; HSP70 Heat-Shock Proteins/genetics ; Kidney Medulla/cytology ; Kidney Medulla/drug effects ; L-Lactate Dehydrogenase/genetics ; L-Lactate Dehydrogenase/metabolism ; NFATC Transcription Factors/genetics ; NFATC Transcription Factors/metabolism ; Prostaglandin-Endoperoxide Synthases/genetics ; Prostaglandin-Endoperoxide Synthases/metabolism ; Saline Solution, Hypertonic/adverse effects

The cells of the renal medulla produce large amounts of prostaglandin E2 (PGE2) via cyclooxygenases (COX)-1 and -2. PGE2 is well known to play a critical role in salt and water balance and maintenance of medullary blood flow. Since renal medullary PGE2 production increases in antidiuresis, and since COX inhibition is associated with damage to the renal medulla during water deprivation, PGE2 may promote the adaptation of renal papillary cells to high interstitial solute concentrations. To address this question, MDCK cells were exposed to a gradual tonicity increase in the presence or absence of 20 microM PGE2 prior to analysis of (i) cell survival, (ii) expression of osmoprotective genes (AR, BGT1, SMIT, HSP70 and COX-2), (iii) subcellular TonEBP/NFAT5 abundance, (iv) TonEBP/NFAT5 transcriptional activity and (v) aldose reductase promoter activity. Cell survival and apoptotic indices after raising the medium tonicity improved markedly in the presence of PGE2. PGE2 significantly increased tonicity-mediated up-regulation of AR, SMIT and HSP70 mRNAs. However, neither nuclear abundance nor TonEBP/NFAT5-driven reporter activity were elevated by PGE2, but aldose reductase promoter activity was significantly increased by PGE2. Interestingly, tonicity-induced COX-2 expression and activity was also stimulated by PGE2, suggesting the existence of a positive feedback loop. These results demonstrate that the major medullary prostanoid, PGE2, stimulates the expression of osmoprotective genes and favours the adaptation of medullary cells to increasing interstitial tonicities, an effect that is not explained directly by the presence of TonEs in the promoter region of the respective target genes. These findings may be relevant in the pathophysiology of medullary damage associated with analgesic drugs.

Mutat Res. 1987 Sep;189(1):15-25. (PMID: 3627148)
Annu Rev Physiol. 1997;59:437-55. (PMID: 9074772)
N Engl J Med. 1998 Feb 12;338(7):446-52. (PMID: 9459649)
Kidney Int. 1999 Mar;55(3):956-62. (PMID: 10027932)
J Biol Chem. 1999 Jul 16;274(29):20185-90. (PMID: 10400634)
Cell Stress Chaperones. 2004 Autumn;9(3):265-75. (PMID: 15544164)
Annu Rev Physiol. 2005;67:531-55. (PMID: 15709969)
J Biol Chem. 2005 Oct 14;280(41):34966-73. (PMID: 16024921)
N Engl J Med. 1995 Mar 9;332(10):647-55. (PMID: 7845430)
Am J Physiol. 1989 Dec;257(6 Pt 1):C1093-100. (PMID: 2610250)
Am J Physiol. 1991 Oct;261(4 Pt 1):C594-601. (PMID: 1718164)
Am J Physiol. 1992 May;262(5 Pt 2):F849-56. (PMID: 1590428)
Methods Enzymol. 1992;216:362-8. (PMID: 1479908)
Kidney Int. 1993 Sep;44(3):643-53. (PMID: 8231040)
Annu Rev Physiol. 2001;63:579-605. (PMID: 11181968)
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1999-2004. (PMID: 11172065)
Nat Cell Biol. 2001 Sep;3(9):839-43. (PMID: 11533664)
J Am Soc Nephrol. 2001 Nov;12(11):2221-30. (PMID: 11675398)
J Am Soc Nephrol. 2001 Dec;12(12):2565-71. (PMID: 11729224)
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):739-44. (PMID: 11792870)
Mol Cell Biol. 2002 Aug;22(16):5753-60. (PMID: 12138186)
J Physiol. 2002 Aug 15;543(Pt 1):147-53. (PMID: 12181287)
Pflugers Arch. 2002 Aug;444(5):579-85. (PMID: 12194010)
Am J Physiol Renal Physiol. 2002 Oct;283(4):F792-8. (PMID: 12217871)
Am J Physiol Renal Physiol. 2003 Feb;284(2):F253-66. (PMID: 12529271)
J Am Soc Nephrol. 2003 Feb;14(2):283-8. (PMID: 12538727)
Acta Physiol Scand. 2003 Apr;177(4):417-21. (PMID: 12648158)
J Biol Chem. 2003 May 23;278(21):19352-7. (PMID: 12637551)
Pediatr Nephrol. 2003 Aug;18(8):826-9. (PMID: 12774222)
Kidney Int. 2004 Feb;65(2):431-41. (PMID: 14717913)
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2392-7. (PMID: 14983020)
J Physiol. 1970 Jun;208(2):68P-69P. (PMID: 5500752)
J Physiol. 1971 May;215(1):42P-43P. (PMID: 5579673)
J Clin Invest. 1986 Nov;78(5):1165-72. (PMID: 3771788)
Am J Physiol. 1995 Dec;269(6 Pt 2):F854-62. (PMID: 8594880)
Physiol Rev. 1996 Apr;76(2):425-536. (PMID: 8618962)
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8624-9. (PMID: 8710921)
Gene. 1988 Jun 15;66(1):1-10. (PMID: 3417148)

0 (Anti-Inflammatory Agents, Non-Steroidal)
0 (Carrier Proteins)
0 (GABA Plasma Membrane Transport Proteins)
0 (HSP70 Heat-Shock Proteins)
0 (NFATC Transcription Factors)
0 (Saline Solution, Hypertonic)
146313-33-9 (betaine plasma membrane transport proteins)
EC 1.1.1.21 (Aldehyde Reductase)
EC 1.1.1.27 (L-Lactate Dehydrogenase)
EC 1.14.99.1 (Prostaglandin-Endoperoxide Synthases)
EC 3.4.22.- (Caspase 3)
K7Q1JQR04M (Dinoprostone)

Date Created: 20070609 Date Completed: 20071030 Latest Revision: 20191210

20231215

PMC2277232

10.1113/jphysiol.2007.135178

17556390